Chrystal U Louis Selected Research

Chrystal U Louis Research Topics

Disease

12	Neoplasms (Cancer) 11/2019 - 10/2009
8	Neuroblastoma 04/2024 - 12/2011
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2018
3	Neoplasm Metastasis (Metastasis) 01/2020 - 08/2014
3	Nasopharyngeal Carcinoma 01/2019 - 07/2007
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023
1	Adenocarcinoma 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 11/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019
1	Surgical Blood Loss 10/2016
1	Vaccinia 03/2015
1	Cytokine Release Syndrome 07/2014
1	Hypotension (Low Blood Pressure) 10/2010
1	Vomiting 10/2010
1	Hypersensitivity (Allergy) 10/2010
1	Nausea 10/2010
1	Breast Neoplasms (Breast Cancer) 10/2009
1	Osteosarcoma (Osteogenic Sarcoma) 10/2009
1	Lymphopenia (Lymphocytopenia) 03/2009
1	Bacterial Infections (Bacterial Infection) 12/2003
1	Edema (Dropsy) 12/2003
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2003
1	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2003

Drug/Important Bio-Agent (IBA)

5	Chimeric Antigen ReceptorsIBA 04/2024 - 10/2009
5	130-nm albumin-bound paclitaxelIBA 01/2020 - 01/2018
5	AntigensIBA 01/2019 - 10/2009
3	Gemcitabine FDA Link 01/2020 - 01/2018
2	NivolumabIBA 01/2020 - 01/2019
2	Somatomedin Receptors (Somatomedin Receptor)IBA 11/2019 - 01/2018
2	IstiratumabIBA 11/2019 - 01/2018
2	3-Iodobenzylguanidine (Iobenguane)IBA 10/2016 - 11/2014
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2015 - 10/2009
1	hydroxide ionIBA 01/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	25-hydroxyvitamin DIBA 01/2021
1	AlbuminsIBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 11/2019
1	tyrosine receptor (receptor, tyrosine)IBA 11/2019
1	LigandsIBA 11/2019
1	Phosphotransferases (Kinase)IBA 11/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2019
1	EBV-encoded nuclear antigen 1IBA 01/2019
1	Bevacizumab (Avastin)FDA Link 01/2019
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019
1	EpitopesIBA 01/2019
1	Leucovorin (Folinic Acid)FDA Link 01/2019
1	Neuregulin-1 (Neuregulin 1)IBA 01/2018
1	histidine-rich proteinsIBA 01/2018
1	Insulin-Like PeptidesIBA 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2015
1	Cancer VaccinesIBA 01/2015
1	Bispecific AntibodiesIBA 07/2014
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 10/2010
1	Diphenhydramine (Benadryl)FDA LinkGeneric 10/2010
1	insulin receptor-related receptor (IRR)IBA 10/2010
1	human ERBB2 proteinIBA 10/2009
1	Monoclonal AntibodiesIBA 10/2009
1	CytokinesIBA 10/2009
1	Interleukin-15 (Interleukin 15)IBA 03/2009
1	PlatinumIBA 07/2007
1	ElectrolytesIBA 12/2003

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 11/2019 - 07/2007
6	Therapeutics 01/2018 - 10/2009
5	Immunotherapy 01/2019 - 10/2009
2	Length of Stay 10/2016 - 06/2012
2	Induction Chemotherapy 10/2016 - 11/2014
2	Radiotherapy 11/2014 - 08/2014
1	Hematopoietic Stem Cell Transplantation 01/2023
1	Transplantation 01/2023
1	Injections 03/2015
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 07/2007